Company profile VERA
After 38 days of this quarter the interest is at 210.0. Based on that we can calculate that during remaining 53 days it will total up to 503.0. Vera Therapeutics expected interest is significantly higher compared to previous quarter (+187.4%) and same quarter last year (+74.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 33 | 77 133.3% QoQ | 96 24.7% QoQ | 108 12.5% QoQ |
| 2020 | 60 81.8% YoY -44.4% QoQ | 70 -9.1% YoY 16.7% QoQ | 44 -54.2% YoY -37.1% QoQ | 78 -27.8% YoY 77.3% QoQ |
| 2021 | 45 -25.0% YoY -42.3% QoQ | 292 317.1% YoY 548.9% QoQ | 193 338.6% YoY -33.9% QoQ | 138 76.9% YoY -28.5% QoQ |
| 2022 | 295 555.6% YoY 113.8% QoQ | 226 -22.6% YoY -23.4% QoQ | 227 17.6% YoY 0.4% QoQ | 149 8.0% YoY -34.4% QoQ |
| 2023 | 289 -2.0% YoY 94.0% QoQ | 149 -34.1% YoY -48.4% QoQ | 101 -55.5% YoY -32.2% QoQ | 175 17.4% YoY 73.3% QoQ |
| 2024 | 210 -27.3% YoY 20.0% QoQ | - | - | - |
The average 5 years interest of Vera Therapeutics was 11.75 per week. The last year interest of Vera Therapeutics compared to the last 5 years has changed by 20.43%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 126.4%.
After 38 days of this quarter the interest is at 89.0. Based on that we can calculate that during remaining 53 days it will total up to 213.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 44 | 163 270.5% QoQ | 38 -76.7% QoQ | 140 268.4% QoQ |
| 2020 | 75 70.5% YoY -46.4% QoQ | 132 -19.0% YoY 76.0% QoQ | 85 123.7% YoY -35.6% QoQ | 148 5.7% YoY 74.1% QoQ |
| 2021 | 24 -68.0% YoY -83.8% QoQ | 211 59.8% YoY 779.2% QoQ | 42 -50.6% YoY -80.1% QoQ | 116 -21.6% YoY 176.2% QoQ |
| 2022 | 103 329.2% YoY -11.2% QoQ | 91 -56.9% YoY -11.7% QoQ | 211 402.4% YoY 131.9% QoQ | 245 111.2% YoY 16.1% QoQ |
| 2023 | 230 123.3% YoY -6.1% QoQ | 147 61.5% YoY -36.1% QoQ | 234 10.9% YoY 59.2% QoQ | 201 -18.0% YoY -14.1% QoQ |
| 2024 | 89 -61.3% YoY -55.7% QoQ | - | - | - |
The average 5 years interest of atacicept was 10.65 per week. The last year interest of atacicept compared to the last 5 years has changed by 38.31%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 85.52%.
After 34 days of this quarter the interest is at 146.0. Based on that we can calculate that during remaining 58 days it will total up to 395.0. immunoglobulin A nephropathy expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+1419.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 43 |
| 2019 | 56 30.2% QoQ | 107 91.1% QoQ | 23 -78.5% QoQ | 91 111.6% YoY 295.7% QoQ |
| 2020 | 74 32.1% YoY -18.7% QoQ | 58 -45.8% YoY -21.6% QoQ | 82 256.5% YoY 41.4% QoQ | 71 -22.0% YoY -13.4% QoQ |
| 2021 | 42 -43.2% YoY -40.8% QoQ | 48 -17.2% YoY 14.3% QoQ | 77 -6.1% YoY 60.4% QoQ | 79 11.3% YoY 2.6% QoQ |
| 2022 | 167 297.6% YoY 111.4% QoQ | 52 8.3% YoY -68.9% QoQ | 16 -79.2% YoY -69.2% QoQ | 26 -67.1% YoY 62.5% QoQ |
| 2023 | 70 -58.1% YoY 169.2% QoQ | 57 9.6% YoY -18.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 146 461.5% YoY inf% QoQ |
The average 5 years interest of immunoglobulin A nephropathy was 5.31 per week. The last year interest of immunoglobulin A nephropathy compared to the last 5 years has changed by 3.58%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 7.21%.
After 38 days of this quarter the interest is at 193.0. Based on that we can calculate that during remaining 53 days it will total up to 462.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 279 | 448 60.6% QoQ | 445 -0.7% QoQ | 486 9.2% QoQ |
| 2020 | 476 70.6% YoY -2.1% QoQ | 446 -0.4% YoY -6.3% QoQ | 536 20.4% YoY 20.2% QoQ | 455 -6.4% YoY -15.1% QoQ |
| 2021 | 554 16.4% YoY 21.8% QoQ | 539 20.9% YoY -2.7% QoQ | 524 -2.2% YoY -2.8% QoQ | 533 17.1% YoY 1.7% QoQ |
| 2022 | 609 9.9% YoY 14.3% QoQ | 603 11.9% YoY -1.0% QoQ | 664 26.7% YoY 10.1% QoQ | 571 7.1% YoY -14.0% QoQ |
| 2023 | 662 8.7% YoY 15.9% QoQ | 582 -3.5% YoY -12.1% QoQ | 612 -7.8% YoY 5.2% QoQ | 650 13.8% YoY 6.2% QoQ |
| 2024 | 193 -70.8% YoY -70.3% QoQ | - | - | - |
The average 5 years interest of lupus nephritis was 41.8 per week. The last year interest of lupus nephritis compared to the last 5 years has changed by 13.64%. The interest for lupus nephritis is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 33.31%.
There is not enough data for MAU868 to provide analysis
There is not enough data for MAU868 to provide correlation calculation
There is not enough data for MAU868 to provide analysis
There is not enough data for BK viremia infections to provide analysis
There is not enough data for BK viremia infections to provide correlation calculation
There is not enough data for BK viremia infections to provide analysis
After 38 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 53 days it will total up to 239.0. Trucode Gene Repair expected interest is significantly higher compared to previous quarter (+52.2%) and same quarter last year (+43.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 125 | 137 9.6% QoQ | 115 -16.1% QoQ | 159 38.3% QoQ |
| 2020 | 148 18.4% YoY -6.9% QoQ | 114 -16.8% YoY -23.0% QoQ | 124 7.8% YoY 8.8% QoQ | 72 -54.7% YoY -41.9% QoQ |
| 2021 | 32 -78.4% YoY -55.6% QoQ | 63 -44.7% YoY 96.9% QoQ | 92 -25.8% YoY 46.0% QoQ | 29 -59.7% YoY -68.5% QoQ |
| 2022 | 85 165.6% YoY 193.1% QoQ | 144 128.6% YoY 69.4% QoQ | 114 23.9% YoY -20.8% QoQ | 109 275.9% YoY -4.4% QoQ |
| 2023 | 167 96.5% YoY 53.2% QoQ | 172 19.4% YoY 3.0% QoQ | 74 -35.1% YoY -57.0% QoQ | 157 44.0% YoY 112.2% QoQ |
| 2024 | 100 -40.1% YoY -36.3% QoQ | - | - | - |
The average 5 years interest of Trucode Gene Repair was 8.97 per week. The last year interest of Trucode Gene Repair compared to the last 5 years has changed by 43.59%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 12.59%.
There is not enough data for clinical stage biotechnology company to provide analysis
There is not enough data for clinical stage biotechnology company to provide correlation calculation
There is not enough data for clinical stage biotechnology company to provide analysis
There is not enough data for serious immunological diseases to provide analysis
There is not enough data for serious immunological diseases to provide correlation calculation
There is not enough data for serious immunological diseases to provide analysis
After 38 days of this quarter the interest is at 312.0. Based on that we can calculate that during remaining 53 days it will total up to 747.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 371 | 548 47.7% QoQ | 583 6.4% QoQ | 528 -9.4% QoQ |
| 2020 | 577 55.5% YoY 9.3% QoQ | 566 3.3% YoY -1.9% QoQ | 651 11.7% YoY 15.0% QoQ | 645 22.2% YoY -0.9% QoQ |
| 2021 | 788 36.6% YoY 22.2% QoQ | 703 24.2% YoY -10.8% QoQ | 718 10.3% YoY 2.1% QoQ | 746 15.7% YoY 3.9% QoQ |
| 2022 | 905 14.8% YoY 21.3% QoQ | 805 14.5% YoY -11.0% QoQ | 894 24.5% YoY 11.1% QoQ | 906 21.4% YoY 1.3% QoQ |
| 2023 | 1017 12.4% YoY 12.3% QoQ | 977 21.4% YoY -3.9% QoQ | 993 11.1% YoY 1.6% QoQ | 1034 14.1% YoY 4.1% QoQ |
| 2024 | 312 -69.3% YoY -69.8% QoQ | - | - | - |
The average 5 years interest of subcutaneous injection was 58.72 per week. The last year interest of subcutaneous injection compared to the last 5 years has changed by 29.75%. The interest for subcutaneous injection is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 75.63%.